About

ORGANIC MEDICAL VENTURES
Executive Summary

Organic Medical Ventures (OMV), was formed in 2008 as an
LLC, in Delaware. OMV has successfully conceptualized, developed, and licensed technology through it's wholly owned subsidiaries.

Naturalock Solutions, LLC is one such subsidiary. Naturalock Solutions, LLC is a medical device development company formed to design, patent, and market medical technology with the goal of becoming the world leader in advanced catheter locking/flushing solutions.

Currently Heparin, normal saline, or a combination of the two is
used for this task. Our proprietary formulation is all natural and non-toxic to humans. It contains an anticoagulant, as well as bactericidal, and anti-fungal properties to guard against infection. The treatment of catheter related blood stream infections cost the health care system over $4 Billion per year.
This project was completed without the involvement of venture capital, using our own resources, in less than 3 years.
Extensive testing has been successfully completed and this life saving technology is poised for regulatory approvals and commercialization.

KR Technologies, LLC is a subsidiary of Organic Medical Ventures, formed for the purpose to develop and market products for the prevention and treatment of muscle cramps, menstrual cramps, and to enhance muscle endurance and recovery.  Following the success of our previous project we are now focused on this exciting technology and are quickly approaching the critical mass needed for a, consumer based, national product launch campaign.  
Management Summary:

Gary Rayburn, BS: Chief Executive Officer & Partner:
Over 25 years experience in research and development, medical device invention, sales, marketing, and management, as well as, start up business development through the acquisition phase, in the fields of vascular surgery, renal therapy, cardiovascular technology, and new pharmaceutical agents. Holds numerous patents in these areas.
Primary focus on project selection, business plan development, implementation, and negotiating with industry for deal structure and acquisition.

Bob Maurer, BS: Chief Operating Officer & Partner:
Over 26 years experience focused on key national accounts, market development, sales and management as well as start up business development in the fields of orthopedic surgery, renal therapies, vascular surgery, and peripheral vascular disease. Primary focus on project funding activity through acquisition.

Marvin A. Cuchens, Ph.D.: Chief Science Officer & Partner:
Over 30 years experience in clinical and basic research focused on chemistry, microbiology, immunology, cancer and flow cytometry, as well as mentor and instructor for medical, dental, and graduate students. Primary focus on safety and efficacy research.